Clinical Trial Update: A Study to Assess Disease Activity in Adult Participants With Axial Spondyloarthritis Who Receive Upadacitinib in a Real-world Setting

View source ↗

Summary

This clinical trial update indicates recruitment for a real-world study evaluating disease activity in adults with axial spondyloarthritis who receive upadaciti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Axial Spondylarthritis (r-axSpA) | Status: RECRUITING